Implantable pulse generator is a battery-powered micro-electronic medical device that is implanted in the body, delivers electric stimulation to the nervous system in order to stimulate or block various nerve impulses in the body. The technology is adapted from the technology used in cardiac rhythm management and holds promise in treatment of variety of medical conditions such as reducing back pain, treatment of hypertension and obesity and curing diabetes without daily injections of insulin. In some situations implantable pulse generators are used to treat such conditions for which medicines either have not been completely effective or have shown some side effects.
Due to the COVID-19 pandemic, the global Implantable Pulse Generator market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Implantable Pulse Generator market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Implantable Pulse Generator landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Unipolar accounting for % of the Implantable Pulse Generator global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Implantable Pulse Generator include Medtronic, Boston Scientific Corporation, Abbott, Synapse Biomedical, Nevro Corporation, Neurosigma, Neuropace, Cyberonics and BioControl Medical. etc. In terms of revenue, the global 3 largest players have a % market share of Implantable Pulse Generator in 2021.
This report focuses on Implantable Pulse Generator volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Implantable Pulse Generator market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Implantable Pulse Generator Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Unipolar
Multipolar
Segment by Application
Hospitals
Ambulatory Surgical Centers
Home Care Settings
Clinics
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Medtronic
Boston Scientific Corporation
Abbott
Synapse Biomedical
Nevro Corporation
Neurosigma
Neuropace
Cyberonics
BioControl Medical